Surface engineering of hollow gold nanoparticle with mesenchymal stem cell membrane and MUC-1 aptamer for targeted theranostic application against metastatic breast cancer
Author:
Funder
Mashhad University of Medical Sciences
Publisher
Elsevier BV
Subject
Pharmaceutical Science,General Medicine,Biotechnology
Reference73 articles.
1. Doxil®—The first FDA-approved nano-drug: Lessons learned;Barenholz;J. Controlled Release,2012
2. Liposomal formulations in clinical use: an updated review;Bulbake;Pharm,2017
3. Theranostic polymeric nanoparticles for NIR imaging and photodynamic therapy;Sarcan;Int. J. Pharm,2018
4. Roles of tumor heterogeneity in the development of drug resistance: a call for precision therapy;Wu;Seminars Can. Biol. Elsevier,2017
5. Breast tumor heterogeneity: source of fitness, hurdle for therapy;Koren;Mol. Cell,2015
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Robust aptamer-targeted CRISPR/Cas9 delivery using mesenchymal stem cell membrane –liposome hybrid: BIRC5 gene knockout against melanoma;Nanomedicine: Nanotechnology, Biology and Medicine;2024-11
2. Targeted doxorubicin-loaded core–shell copper peroxide-mesoporous silica nanoparticles for combination of ferroptosis and chemotherapy of metastatic breast cancer;International Journal of Pharmaceutics;2024-09
3. Nucleolin-targeted doxorubicin and ICG co-loaded theranostic lipopolymersome for photothermal-chemotherapy of melanoma in vitro and in vivo;European Journal of Pharmaceutics and Biopharmaceutics;2024-09
4. Synergistic Photothermal Therapy and Chemotherapy Enabled by Tumor Microenvironment-Responsive Targeted SWCNT Delivery;International Journal of Molecular Sciences;2024-08-23
5. A Review: Surface Engineering of Lipid‐Based Drug Delivery Systems;Small;2024-07-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3